NCT04502914

Brief Summary

Burns are one of the common forms of trauma and are a cause of unintentional death and injury. Management of burns becomes complex due to multiple associated complications, for instance, secondary infection of burn wounds is the most common complication associated with burn injuries. Treatment of bacterial infections with antibiotics is becoming more challenging due to the development of multidrug-resistance. Hence, there is a critical need to investigate and establish non-antibiotic approaches to prevent colonization, control growth, and eliminate bacteria from burn wounds. Recent studies have explored the beneficial effects of open-to-air strategies on wound healing. Based on the evidence, the investigators hypothesize that bacterial load in burn wounds will be lowered when treated with an open-to-air strategy compared to the traditional closed wound approach.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Nov 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 29, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 6, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

November 1, 2020

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 9, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 9, 2021

Completed
Last Updated

January 5, 2022

Status Verified

December 1, 2021

Enrollment Period

7 months

First QC Date

July 29, 2020

Last Update Submit

December 14, 2021

Conditions

Outcome Measures

Primary Outcomes (5)

  • The bacterial load at baseline for each treatment

    Scrapings of the superficial wound exudate and debris will be obtained at baseline (i.e., the 0-time point before implementing any the tested wound care management option) from both wound sites of each patient. The colony-forming units (CFUs) will be enumerated and CFUs/g will be calculated for treatment and control.

    At baseline

  • The bacterial load on day 1 for each treatment

    Scrapings of the superficial wound exudate and debris will be obtained on day 1 (about 24 hours after obtaining samples for baseline measurement) from both wound sites of each patient. The colony-forming units (CFUs) will be enumerated and CFUs/g will be calculated for treatment and control.

    On day 1

  • The bacterial load on day 2 for each treatment

    Scrapings of the superficial wound exudate and debris will be obtained on day 2 (about 48 hours after obtaining samples for baseline measurement) from both wound sites of each patient. The colony-forming units (CFUs) will be enumerated and CFUs/g will be calculated for treatment and control.

    On day 2

  • Difference in change in bacterial load for day 1

    Change in bacterial load from baseline and day 1 and compared between treatment and control groups.

    Change in bacterial load from baseline and day 1

  • Difference in change in bacterial load for day 2

    Change in bacterial load from baseline and day 2 and compared between treatment and control groups.

    Change in bacterial load from baseline and day 2

Secondary Outcomes (3)

  • Prevalence of bacterial species at baseline for each treatment

    At baseline

  • Prevalence of bacterial species on day 1 for each treatment

    On day 1

  • Prevalence of bacterial species on day 1 for each treatment

    On day 2

Study Arms (2)

The experimental group

EXPERIMENTAL

The experimental group will consist of wounds treated with the open-to-air strategy.

Procedure: Open-to-air strategy

The control group

OTHER

The control group will consist of wounds treated with traditional closed-wound management with dressings soaked in topical antimicrobial solutions.

Procedure: Traditional closed-wound management

Interventions

In open-to-air management, the wound will be washed with a chlorhexidine solution and leave the wound open, or portion of the wound assigned to OTA, to the environment. An electric heat lamp (model no. 53103, 250W, Brandt Industries LLC, Bronx, NY) will be placed at as close to 1 yard (0.91 m) as possible from the wound after daily wound care for 24 hours (+/- 6 hours) to promote drying. However, to prevent excessive drying an hourly spritz of topical solution, e.g., DuoDERM® Hydroactive® gel (ConvaTec Oklahoma City, OK) will be used at the bedside.

The experimental group

In traditional closed-wound management, once a day the wound will be washed with a chlorhexidine solution and closed with a non-adherent dressing such as ADAPTIC® (Acelity, San Antonio, TX) soaked in topical antimicrobial solutions, ointments, and creams designed to promote wound healing.

The control group

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 to 89
  • Burn patients with TBSA≥ 20%
  • Any suspicion of skin colonization or infection based on a positive result of microbiologic testing. Testing would only be performed if the attending surgeon treating the patient had a clinical suspicion of wound infection.

You may not qualify if:

  • \. Children

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Texas Tech University Health Sciences Center

Lubbock, Texas, 79430, United States

Location

Related Publications (2)

  • Yang D, Davies A, Burge B, Watkins P, Dissanaike S. Open-to-Air Is a Viable Option for Initial Wound Care in Necrotizing Soft Tissue Infection that Allows Early Detection of Recurrence without Need for Painful Dressing Changes or Return to Operating Room. Surg Infect (Larchmt). 2018 Jan;19(1):65-70. doi: 10.1089/sur.2017.080. Epub 2017 Dec 6.

  • Dai T, Gupta A, Huang YY, Yin R, Murray CK, Vrahas MS, Sherwood ME, Tegos GP, Hamblin MR. Blue light rescues mice from potentially fatal Pseudomonas aeruginosa burn infection: efficacy, safety, and mechanism of action. Antimicrob Agents Chemother. 2013 Mar;57(3):1238-45. doi: 10.1128/AAC.01652-12. Epub 2012 Dec 21.

MeSH Terms

Conditions

BurnsWound InfectionBacterial Infections

Condition Hierarchy (Ancestors)

Wounds and InjuriesInfectionsBacterial Infections and Mycoses
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The experimental group will consist of wounds treated with the open-to-air strategy. The control group will consist of wounds treated with traditional closed-wound management with dressings soaked in topical antimicrobial solutions.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 29, 2020

First Posted

August 6, 2020

Study Start

November 1, 2020

Primary Completion

June 9, 2021

Study Completion

June 9, 2021

Last Updated

January 5, 2022

Record last verified: 2021-12

Data Sharing

IPD Sharing
Will not share

Locations